BDBM689087 N-(4-((sec- Butylamino)methyl)benzyl)-6- ((S)-6-chloro-5-fluoro-2-oxo- 1,2- dihydrospiro[benzo[d][1,3] oxazine-4,3'-pyrrolidin]-1'- yl)pyridazine-4-carboxamide::US20240190892, Example 45

SMILES CCC(C)NCc1ccc(CNC(=O)c2cnnc(c2)N2CC[C@]3(C2)OC(=O)Nc2ccc(Cl)c(F)c32)cc1

InChI Key InChIKey=FLSZPURICKQPBW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 689087   

TargetPlasma kallikrein(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM689087(US20240190892, Example 45 | N-(4-((sec- Butylamino...)
Affinity DataIC50: 15.8nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of plasma kallikrein can be determined using a relevant purified serine prot...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM689087(US20240190892, Example 45 | N-(4-((sec- Butylamino...)
Affinity DataIC50: 1.00E+4nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation factor XIa can be determined using a relevant purified serine...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2024
Entry Details
Go to US Patent